Since 1999, most innovative treatment approaches for treatment of insulin-dependent diabetes have focused on protect beta cell of pancreatic langerhanc islet against auto immunity or replace these cells with insulin producing cells since 1999 [8, 9]. This evidence concerns the gene INS and type 1 diabetes mellitus.